{"id":1686,"date":"2026-07-01T19:35:09","date_gmt":"2026-07-01T23:35:09","guid":{"rendered":"https:\/\/www.insilens.com\/?p=1686"},"modified":"2026-07-01T19:37:32","modified_gmt":"2026-07-01T23:37:32","slug":"ipsen-to-acquire-memo-therapeutics-for-up-to-eur700m","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=1686","title":{"rendered":"Ipsen to Acquire Memo Therapeutics for Up to EUR700M"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1686\" class=\"elementor elementor-1686\">\n\t\t\t\t<div class=\"elementor-element elementor-element-79e5bbe1 e-flex e-con-boxed e-con e-parent\" data-id=\"79e5bbe1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-69729cfd elementor-widget elementor-widget-image\" data-id=\"69729cfd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"512\" src=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/07\/ChatGPT-Image-Jul-1-2026-07_33_48-PM-768x512.png\" class=\"attachment-medium_large size-medium_large wp-image-1687\" alt=\"\" srcset=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/07\/ChatGPT-Image-Jul-1-2026-07_33_48-PM-768x512.png 768w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/07\/ChatGPT-Image-Jul-1-2026-07_33_48-PM-300x200.png 300w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/07\/ChatGPT-Image-Jul-1-2026-07_33_48-PM-1024x683.png 1024w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/07\/ChatGPT-Image-Jul-1-2026-07_33_48-PM.png 1536w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6f85a987 e-flex e-con-boxed e-con e-parent\" data-id=\"6f85a987\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-780dec52 elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"780dec52\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Summary<\/h4><p>Ipsen will acquire Memo Therapeutics for up to EUR700M including EUR200M upfront, adding potravitug, a Phase 2 monoclonal antibody for BK polyomavirus-associated nephropathy in kidney transplant recipients.<\/p><h4>What Happened<\/h4><p>The acquisition strengthens Ipsen&#8217;s rare disease portfolio and supports a planned pivotal Phase 2\/3 study later this year.<\/p><h4>Deep Analysis<\/h4><p>BKPyVAN is a major cause of graft dysfunction after kidney transplantation with no approved targeted therapy. Potravitug could become a first-in-class biologic and is relevant to transplant immunology and immunocompromised patient care.<\/p><h4>Related News<\/h4><p>Complements Ipsen&#8217;s recent Kartos acquisition while expanding beyond oncology.<\/p><h4>Competitive Displacement<\/h4><p>Success would establish a targeted treatment paradigm beyond immunosuppression reduction.<\/p><h4>Insilens Take<\/h4><p>Strategically relevant adjacent signal for transplant medicine and immune-compromised patient management.<\/p><h1>\u00a0<\/h1>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Summary Ipsen will acquire Memo Therapeutics for up to EUR700M including EUR200M upfront, adding potravitug, a Phase 2 monoclonal antibody for BK polyomavirus-associated nephropathy in kidney transplant recipients. What Happened The acquisition strengthens Ipsen&#8217;s rare disease portfolio and supports a planned pivotal Phase 2\/3 study later this year. Deep Analysis BKPyVAN is a major cause [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1687,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,2],"tags":[],"class_list":["post-1686","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-categories","category-deals-and-financing"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1686"}],"version-history":[{"count":4,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1686\/revisions"}],"predecessor-version":[{"id":1691,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1686\/revisions\/1691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/1687"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}